Search
for
Sort by
Research 331–360 of 1000+
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Hair metal dysregulation in Parkinson’s disease: Implications for diagnosis and gut-brain axis involvement
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
- Faculty Opinions recommendation of Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Association between PITX2 polymorphism and androgenetic alopecia in the Indian population
- Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults
- Association Between Androgenetic Alopecia and Dyslipidemia in Male Patients: Evidence From a Hospital-Based Study
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Teriflunomide in multiple sclerosis: an update
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Dermatoses of pregnancy
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Polycystic ovary syndrome: a dermatologic approach
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review